Using nanoparticles, not needles, to deliver drugs into the eye nets Kala … – MedCity News

MedCity News
Kala also plans to conduct an exploratory trial in diabetic macular edema and retinal vein occlusion. It’s also advancing a small molecule treatment for wet age-related macular degeneration. Kala was founded by Langer at MIT, Dr. Justin Hanes at Johns …

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment